dia x pro taper
Showing 1 - 25 of 7,714
Dental Pulp Diseases Trial in Karachi (Finishing files of ProTaper Gold (F2) without effect to NaOCL, Finishing files of
Completed
- Dental Pulp Diseases
- Finishing files of ProTaper Gold (F2) without effect to NaOCL
- +3 more
-
Karachi, Sindh, PakistanDow university of Health Sciences
Apr 2, 2022
Post Endodontic Pain Trial in Ajman (ProTaper Ultimate, ProTaper Gold)
Recruiting
- Post Endodontic Pain
- ProTaper Ultimate
- ProTaper Gold
-
Ajman, United Arab EmiratesGulf Medical University
Feb 28, 2023
Diarrhea Trial in Hanoi (LiveSpo DIA30, LiveSpo CLAUSY, RO)
Recruiting
- Diarrhea
- LiveSpo DIA30
- +2 more
-
Hanoi, VietnamDepartment of Gastroenterology, Vietnam National Children's Hosp
Apr 12, 2023
Diabete Mellitus Trial (Dexcom Professional Continuous Glucose Monitoring)
Withdrawn
- Diabete Mellitus
- Dexcom Professional Continuous Glucose Monitoring
- (no location specified)
Jul 1, 2022
Diabetic Peripheral Neuropathic Pain Trial in Southfield (CBD/PEA, Placebo)
Not yet recruiting
- Diabetic Peripheral Neuropathic Pain
- CBD/PEA
- Placebo
-
Southfield, MichiganPure Green Pharmaceuticals Inc.
Mar 2, 2023
My Health Day by Day (Mi Salud Dia a Dia)
Recruiting
- Stress, Emotional
-
Miami, FloridaUniversity of Miami
Sep 16, 2022
Diabetes, Type 2 Trial in Basel (Dapansutrile, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Dapansutrile
- Placebo
-
Basel, SwitzerlandUniversity Hospital Basel
Sep 21, 2023
Arthritis Knee, Arthritis Hip, Chronic Pain Trial in Birmingham (opioid taper)
Not yet recruiting
- Arthritis Knee
- +2 more
- opioid taper
-
Birmingham, AlabamaUAB Hospital-Highlands
Mar 15, 2023
Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)
Recruiting
- Takayasu Arteritis (TAK)
- Upadacitinib
- +2 more
-
Salvador, Bahia, Brazil
- +44 more
Aug 22, 2022
Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)
Recruiting
- Advanced Breast Cancer
- TQB3909 tablets
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Mar 16, 2023
Opioid Use Disorder, Opioid Withdrawal, Opioid Craving Trial in Baltimore (Buspirone, Lofexidine, Placebo)
Not yet recruiting
- Opioid Use Disorder
- +3 more
- Buspirone
- +2 more
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Aug 19, 2022
Knee Arthritis Trial in Atlanta, Tucker (Methylprednisolone, Standard of Care)
Not yet recruiting
- Knee Arthritis
- Methylprednisolone
- Standard of Care
-
Atlanta, Georgia
- +1 more
May 5, 2023
Substance Use Disorders, Anxiety Disorders, Chronic Pain Trial in Burbank (Benzodiazepine Taper, Cognitive Behavioral Therapy
Recruiting
- Substance Use Disorders
- +2 more
- Benzodiazepine Taper
- +2 more
-
Burbank, CaliforniaUCLA Health MPTF Toluca Lake Primary Care Clinic
Apr 25, 2023
Gastric Cancer, Signet Ring Cell Carcinoma Trial in Hangzhou (Without any intervention)
Active, not recruiting
- Gastric Cancer
- Signet Ring Cell Carcinoma
- Without any intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Aug 2, 2023
Total Knee Arthroplasty Trial in Chicago (Methylprednisolone, Placebo)
Recruiting
- Total Knee Arthroplasty
- Methylprednisolone
- Placebo
-
Chicago, IllinoisRush University medical Center
Apr 26, 2022
Cancer Trial in Philadelphia (Encounter-based PRO monitoring, Remote PRO monitoring)
Not yet recruiting
- Cancer
- Encounter-based PRO monitoring
- Remote PRO monitoring
-
Philadelphia, PennsylvaniaAbramson Cancer Center
Aug 24, 2023
Giant Cell Arteritis (GCA) Trial in Worldwide (Secukinumab 300 mg, Placebo)
Recruiting
- Giant Cell Arteritis (GCA)
- Secukinumab 300 mg
- +2 more
-
Fontana, California
- +83 more
Nov 10, 2022
Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)
Recruiting
- Giant Cell Arteritis
- Secukinumab 300 mg, s.c.
- Placebo to match Secukinumab, s.c.
-
Berlin, Germany
- +2 more
Oct 12, 2022
Evaluating the SUBLOCADE Treatment Exit Strategy
Not yet recruiting
- Opioid Use Disorder
- (no location specified)
May 17, 2023
Total Knee Arthroplasty Trial in Oak Brook (Methylprednisolone, Placebo)
Recruiting
- Total Knee Arthroplasty
- Methylprednisolone
- Placebo
-
Oak Brook, IllinoisRush Oak Brook Outpatient Center
Nov 15, 2022
Satisfaction, Quality of Life Trial in L'Hospitalet De Llobregat (XC mouthguard, XP mouthguard)
Completed
- Satisfaction
- Quality of Life
- XC mouthguard
- XP mouthguard
-
L'Hospitalet De Llobregat, Catalonia, SpainJordi Martinez-Gomis
Nov 2, 2022
Polymyalgia Rheumatica Trial in Denmark (Treat-to-target Prednisolone Taper, Usual care)
Recruiting
- Polymyalgia Rheumatica
- Treat-to-target Prednisolone Taper
- Usual care
-
Aalborg, Denmark
- +7 more
Jan 31, 2023
Neonatal Opiate Withdrawal Syndrome Trial in United States (Symptom-based Dosing Approach, Scheduled Opioid Taper Approach)
Not yet recruiting
- Neonatal Opiate Withdrawal Syndrome
- Symptom-based Dosing Approach
- Scheduled Opioid Taper Approach
-
Birmingham, Alabama
- +8 more
Jul 27, 2023
Exercise Trial in New York (Graded-Intensity Treadmill Exercise Protocol)
Not yet recruiting
- Exercise
- Graded-Intensity Treadmill Exercise Protocol
-
New York, New YorkTisch Hospital
Jun 20, 2023